Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001193125-14-194964
Filing Date
2014-05-12
Accepted
2014-05-12 16:43:52
Documents
10
Period of Report
2014-03-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q d722563d10q.htm 10-Q 281912
2 EX-31.1 d722563dex311.htm EX-31.1 9218
3 EX-31.2 d722563dex312.htm EX-31.2 9839
4 EX-32.1 d722563dex321.htm EX-32.1 5129
  Complete submission text file 0001193125-14-194964.txt   2162863

Data Files

Seq Description Document Type Size
5 XBRL INSTANCE DOCUMENT hrtx-20140331.xml EX-101.INS 253125
6 XBRL TAXONOMY EXTENSION SCHEMA hrtx-20140331.xsd EX-101.SCH 22036
7 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE hrtx-20140331_cal.xml EX-101.CAL 14991
8 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE hrtx-20140331_def.xml EX-101.DEF 103942
9 XBRL TAXONOMY EXTENSION LABEL LINKBASE hrtx-20140331_lab.xml EX-101.LAB 185246
10 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE hrtx-20140331_pre.xml EX-101.PRE 105987
Mailing Address 123 SAGINAW DRIVE 123 SAGINAW DRIVE REDWOOD CITY CA 94063
Business Address 123 SAGINAW DRIVE REDWOOD CITY CA 94063 6503662626
HERON THERAPEUTICS, INC. /DE/ (Filer) CIK: 0000818033 (see all company filings)

EIN.: 942875566 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-33221 | Film No.: 14833926
SIC: 2834 Pharmaceutical Preparations